HOME >> MEDICINE >> NEWS
New understanding of neural circuits may help development of thought-controlled prosthetic devices

SAN DIEGO, Oct. 25 -- You can read this release, and more generally, function in the world, thanks to precise communications between circuits of millions of nerve cells in your brain and spinal cord. Once a mystery, new studies now decipher some of this complex chatter.

The new research was presented at the 34th Society for Neuroscience annual meeting in San Diego.

"The clinical implications of this type of basic science research are enormous," says Gyrgy Buzski, MD, PhD, of Rutgers University , an expert on neural circuits. "By understanding the communication process of normal neural circuits, we can determine ways to help those who experience an injury or have a disorder that has damaged their circuits and impaired their function."

For example, the research will likely aid the development of "thought-controlled prosthetic devices," which could help amputees or those with paralysis who can't use their limbs. Normally circuits of nerve cells in the brain constantly compute and transmit complex signals through the spinal cord and out peripheral nerves in order to move an arm, hand, leg, or foot. An injury that causes the loss of a limb or damage to the spinal cord can sever this communication line and prevent desired movement. In theory, a thought-controlled prosthetic device, also known as a brain-machine interface, could bypass the loss or damage by directly interpreting nerve cell signals and then launching movement in a prosthetic limb.

The development of these devices requires a two-pronged, parallel approach. "The first is the understanding of the self-organized nature of healthy neural circuits," says Buzski. "Second is the use of this information to control prosthetic devices and feed back information from them to the brain." Researchers will report the latest advances in device development in the press conference on prosthetic devices, which will follow this press conference. This session will focus on the
'"/>

Contact: Leah Ariniello
dawn@sfn.org
202-462-6688
Society for Neuroscience
24-Oct-2004


Page: 1 2 3 4

Related medicine news :

1. Monkey pay-per-view study could aid understanding of autism
2. Another step towards understanding the causes of narcolepsy
3. Student nurses need better understanding of poverty-stricken patients
4. Signaling pathway may be key to understanding roots of hypertension
5. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
6. Researchers develop better understanding of tamoxifen resistance in breast cancer patients
7. New study highlights misunderstanding surrounding risks and benefits of tamoxifen
8. Study expands understanding of alcoholic memory disorder
9. Research breakthrough in understanding treatment resistant depression
10. New study provides molecular-level understanding of common anti-malarial drugs
11. New research adds to understanding of conscious awareness

Post Your Comments:
(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: